Table 2.
Cancer specific characteristic and comorbidities of participants.
| Characteristics | Intervention (n = 46) | Control (n = 45) | ||
|---|---|---|---|---|
| n | (%) | n | (%) | |
| Cancer type | ||||
| Breast | 21 | (45.7) | 17 | (37.8) |
| Prostate | 9 | (19.6) | 11 | (24.4) |
| Colorectal | 5 | (10.9) | 4 | (8.9) |
| Head and neck | 3 | (6.5) | 3 | (6.7) |
| Gynaecologic * | 1 | (2.2) | 2 | (4.4) |
| Lung | 1 | (2.2) | 0 | (0) |
| Other | 6 | (13.0) | 8 | (17.8) |
| No. of cancers | ||||
| 1 | 39 | (84.8) | 39 | (86.7) |
| >1 | 7 | (15.2) | 6 | (13.3) |
| Time since first cancer diagnosis, y | ||||
| <2 | 3 | (6.5) | 1 | (2.2) |
| 2–5 | 25 | (54.3) | 26 | (57.8) |
| 6–9 | 11 | (23.9) | 6 | (13.3) |
| ≥10 | 6 | (13.0) | 9 | (20.0) |
| Comorbidity | ||||
| Diabetes II | 4 | (8.7) | 3 | (6.5) |
| Arthritis | 5 | (10.9) | 5 | (11.1) |
| Hypertension | 12 | (26.1) | 13 | (28.3) |
| High cholesterol | 10 | (21.8) | 9 | (20.0) |
Abbreviations: y, years. Note: * Gynaecologic cancers include cervical, uterine, and ovarian cancer. Missing values are present where percentages do not add up to 100 percent.